The Economist features groundbreaking research on human breast milk and the story of HAMLET

Hamlet Biopharma
|
September 12, 2024

Hamlet BioPharma is pleased to announce a recent article about human breast milk in The Economist, a leading international newspaper. The article highlights the pioneering work on HAMLET being conducted at Lund University, exploring the remarkable therapeutic properties of breast milk components in treating cancer and other diseases.

“This is important recognition of our findings and supports the relevance of our approach to developing novel cancer treatments.” says Catharina Svanborg, Lund University and Hamlet BioPharma.

Read the article in The Economist here: https://www.economist.com/science-and-technology/2024/09/11/breast-milks-benefits-are-not-limited-to-babies. An account is required to be able to read the full article

 

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.